GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » J.B. Chemicals & Pharmaceuticals Ltd (BOM:506943) » Definitions » Cyclically Adjusted Revenue per Share

J.B. Chemicals & Pharmaceuticals (BOM:506943) Cyclically Adjusted Revenue per Share : ₹144.41 (As of Mar. 2024)


View and export this data going back to 1991. Start your Free Trial

What is J.B. Chemicals & Pharmaceuticals Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

J.B. Chemicals & Pharmaceuticals's adjusted revenue per share data for the fiscal year that ended in Mar. 2024 was ₹219.720. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ₹144.41 for the trailing ten years ended in Mar. 2024.

During the past 12 months, J.B. Chemicals & Pharmaceuticals's average Cyclically Adjusted Revenue Growth Rate was 14.20% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 15.00% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 12.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of J.B. Chemicals & Pharmaceuticals was 15.00% per year. The lowest was 5.50% per year. And the median was 9.20% per year.

As of today (2024-05-31), J.B. Chemicals & Pharmaceuticals's current stock price is ₹ 1768.65. J.B. Chemicals & Pharmaceuticals's Cyclically Adjusted Revenue per Share for the fiscal year that ended in Mar. 2024 was ₹144.41. J.B. Chemicals & Pharmaceuticals's Cyclically Adjusted PS Ratio of today is 12.25.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of J.B. Chemicals & Pharmaceuticals was 13.08. The lowest was 1.77. And the median was 6.77.


J.B. Chemicals & Pharmaceuticals Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for J.B. Chemicals & Pharmaceuticals's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

J.B. Chemicals & Pharmaceuticals Cyclically Adjusted Revenue per Share Chart

J.B. Chemicals & Pharmaceuticals Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 86.61 94.93 107.98 126.40 144.41

J.B. Chemicals & Pharmaceuticals Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 126.40 - - - 144.41

Competitive Comparison of J.B. Chemicals & Pharmaceuticals's Cyclically Adjusted Revenue per Share

For the Drug Manufacturers - Specialty & Generic subindustry, J.B. Chemicals & Pharmaceuticals's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


J.B. Chemicals & Pharmaceuticals's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, J.B. Chemicals & Pharmaceuticals's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where J.B. Chemicals & Pharmaceuticals's Cyclically Adjusted PS Ratio falls into.



J.B. Chemicals & Pharmaceuticals Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, J.B. Chemicals & Pharmaceuticals's adjusted Revenue per Share data for the fiscal year that ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=219.72/153.0345*153.0345
=219.720

Current CPI (Mar. 2024) = 153.0345.

J.B. Chemicals & Pharmaceuticals Annual Data

Revenue per Share CPI Adj_RevenuePerShare
201503 61.834 97.163 97.390
201603 68.866 102.518 102.800
201703 77.245 105.196 112.373
201803 82.401 109.786 114.861
201903 97.957 118.202 126.823
202003 109.526 124.705 134.407
202103 132.147 131.771 153.472
202203 156.705 138.822 172.749
202303 201.100 146.865 209.548
202403 219.720 153.035 219.720

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


J.B. Chemicals & Pharmaceuticals  (BOM:506943) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

J.B. Chemicals & Pharmaceuticals's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=1768.65/144.41
=12.25

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of J.B. Chemicals & Pharmaceuticals was 13.08. The lowest was 1.77. And the median was 6.77.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


J.B. Chemicals & Pharmaceuticals Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of J.B. Chemicals & Pharmaceuticals's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


J.B. Chemicals & Pharmaceuticals (BOM:506943) Business Description

Traded in Other Exchanges
Address
Appa Saheb Marathe Marg, Cnergy IT Park, Unit A2, 3rd floor, Unit A, 8th floor, Prabhadevi, Mumbai, MH, IND, 400 025
J.B. Chemicals & Pharmaceuticals Ltd is an India-based pharmaceutical company. It manufactures and markets pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients (APIs). The company's products include various pharmaceutical dosage forms like tablets, injectable, creams, ointments, lozenges, herbal liquids, and capsules. It also offers services including optimization of formulations, scale-up services, stability testing, regulatory support, packaging design, and commercial production. The group derives revenue from the manufacturing and marketing of a diverse range of pharmaceutical products. The company sells its products in India and also exports them to other international countries.

J.B. Chemicals & Pharmaceuticals (BOM:506943) Headlines

No Headlines